Review
Nucleoside transporters: molecular biology and implications for therapeutic development

https://doi.org/10.1016/S1357-4310(99)01459-8Get rights and content

The uptake of nucleosides (or nucleobases) is essential for nucleic acid synthesis in many human cell types and in parasitic organisms that cannot synthesize nucleotides de novo. The transporters responsible are also the route of entry for many cytotoxic nucleoside analogues used in cancer and viral chemotherapy. Moreover, by regulating adenosine concentrations in the vicinity of its cell-surface receptors, nucleoside transporters profoundly affect neurotransmission, vascular tone and other processes. The recent molecular characterization of two families of human nucleoside transporters has provided new insights into the mechanisms of natural nucleoside and drug uptake and into future developments of improved therapies.

References (56)

  • FaalandC.A.

    Molecular characterization of two novel transporters from human and mouse kidney and from LLC-PK1 cells reveals a novel conserved family that is homologous to bacterial and Aspergillus nucleobase transporters

    Biochim. Biophys. Acta

    (1998)
  • SundaramM.

    Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs

    J. Biol. Chem.

    (1998)
  • MullaneK. et al.

    Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine

    J. Mol. Cell Cardiol.

    (1995)
  • BarrettM. et al.

    The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes

    Parasitol. Today

    (1999)
  • De KoningH.P. et al.

    Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei

    J. Biol. Chem.

    (1998)
  • TyeC-K.

    An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes

    Bioorgan. Med. Chem. Lett.

    (1998)
  • CohenJ.L. et al.

    Would suicide gene therapy solve the T-cell dilemma of allogeneic bone marrow transplantation?

    Immunol. Today

    (1999)
  • CrabbeJ.C.

    Identifying genes for alcohol and drug sensitivity: recent progress and future directions

    Trends Neurosci.

    (1999)
  • FarinaC. et al.

    Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents

    Drug Discovery Today

    (1999)
  • WoodwardK. et al.

    Proteolipid protein gene: Pelizaeus-Merzbacher disease in humans and neurodegeneration in mice

    Trends Genet.

    (1999)
  • AllenG.E.

    Genetics, eugenics and the medicalization of social behaviour: lessons from the past

    Endeavour

    (1999)
  • MooreK.J.

    Utilization of mouse models in the discovery of human disease genes

    Drug Discovery Today

    (1999)
  • HowardM.C.

    MHC-based diagnostics and therapeutics —clinical applications for disease-linked genes

    Immunol. Today

    (1999)
  • SangsterN.C. et al.

    Pharmacology of anthelmintic infection

    Parasitol. Today

    (1999)
  • MurrayA.W.

    The biological significance of purine salvage

    Annu. Rev. Biochem.

    (1971)
  • Cass, C.E. et al. Nucleoside transporters of mammalian cells, in Membrane Transporters as Targets (Amidon G., Sadee W.,...
  • OssesN. et al.

    Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter

    Biochem. J.

    (1996)
  • WangJ.

    Functional and molecular characteristics of Na+-dependent nucleoside transporters

    Pharm. Res.

    (1997)
  • Cited by (307)

    • Latest developments in chemotherapy for metastatic pancreatic cancer

      2019, Theranostic Approach for Pancreatic Cancer
    • Drug delivery to the brain

      2019, Nanomaterials for Drug Delivery and Therapy
    View all citing articles on Scopus
    1

    Tel: +44 113 233 3173 Fax: +44 113 233 3167.

    View full text